June 10, 2005
Drug Firms Control Trials, Study Finds
Academic medical centers tolerate widely differing levels of drug-company control of the clinical trials they conduct, according to a study published last month in The New England Journal of Medicine.
In the study, researchers report that no consensus exists on many issues in industry-financed clinical research, such as whether pharmaceutical-company sponsors can draft manuscripts to be published in cooperation with academic researchers.
The study suggests that such diversity in
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
